Compounded Tirzepatide
NO CONTRACTS • FROM FDA-REGISTERED OUTSOURCING FACILITIES
Our GLP-2 weight loss medication is a weekly prescribed injection of compounded tirzepatide. Compounded Tirzepatide mimic the effect of the hormones GLP-1 and GIP and contains the same active ingredient as Mounjaro® and Zepbound®*.
Through our partnerships with FDA-registered outsourcing facilities, Thrive provides prescribed access to compounded tirzepatide. However, unlike name-brand weight loss injections, Thrive’s injections are not preloaded in injection pens—but don’t worry, Thrive will provide you with step-by-step guidance on how to administer your injection.

Thrive currently offers GLP-2 as an injectable.
Titrated Dosage: An option where you can adjust dosage as needed.
FAQs
GLP-2 comes in single-use, pre-filled syringes. Each syringe is 1 dose. To use the syringe, simply remove the cap and inject into the skin in the upper arm, belly or thigh. The medication will be delivered subcutaneously.
Once per week. Choose a day that is convenient for you, and set a reminder so that you don’t forget!
The starting dose is a low dose, which is taken once weekly for a month. The dose can then be increased, also taken for a month. The dose can be further be increased every month, up to a maximum dose. This process can take up to 20 weeks.
To learn more about our Compounded Tirzepatide options call or text our office at (303) 790-8446 for a free phone consultation today!
*Mounjaro® (tirzepatide) and Zepbound® (tirzepatide) are not compounded. Mounjaro® is FDA-approved for the treatment of type 2 diabetes but may be prescribed off-label for weight loss at a healthcare provider’s discretion. Zepbound® is FDA-approved for chronic weight management.
**Items shown in the picture are intended only as an example. Additionally, product and packaging images are for marketing purposes and may not represent the actual packaging received.
TEXT OR CALL (303) 790-8446 TO SCHEDULE AN APPOINTMENT
Free consultations are provided via text or over the phone only.